Sec. 4. Liver cancer and disease prevention, awareness, and patient tracking grants

579 words·~3 min read·/bill/116/s/3074/is/section-4

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Subpart I of part D of title III of the Public Health Service Act ( 42 U.S.C. 254b et seq.) is amended by adding at the end the following new section: The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may award grants and enter into cooperative agreements with entities for the purpose of expanding and supporting— prevention activities (including providing screenings, vaccinations, or other preventative treatment) for conditions known to increase an individual’s risk of developing a major liver disease, such as liver cancer, hepatitis B, hepatitis C, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and cirrhosis of the liver; activities relating to surveillance, diagnostics, and provision of guidance for individuals at high risk for contracting liver cancer and other liver diseases; and a robust hepatitis surveillance infrastructure to provide for timely and accurate information regarding progress to eliminate viral hepatitis.

An entity that receives a grant or cooperative agreement under paragraph

(1)shall submit to the Secretary, at a time specified by the Secretary, a report describing each activity carried out pursuant to such paragraph and evaluating the effectiveness of such activity in promoting prevention and treatment of liver cancer and other liver diseases. For purposes of carrying out this subsection, there is authorized to be appropriated $90,000,000 for each of fiscal years 2020 through 2024. Any amounts appropriated under this paragraph shall remain available until expended and shall be used to supplement and not supplant other Federal funds provided for activities under this subsection. The Secretary, acting through the Director of the Centers for Disease Control and Prevention, may award grants to eligible entities for the purpose of raising awareness for liver cancer and other liver diseases, which may include the production, dissemination, and distribution of informational materials targeted towards communities and populations with a higher risk for developing liver cancer and other liver diseases. To be eligible to receive a grant under paragraph (1), an entity shall submit to the Secretary an application, at such time, in such manner, and containing such information as the Secretary may require, including a description of how the entity, in disseminating information on liver cancer and other liver diseases pursuant to paragraph (1), will— with respect to any community or population, consult with members of such community or population and provide such information in a manner that is culturally and linguistically appropriate for such community or population; highlight the range of treatments available for liver cancer and other liver diseases; integrate information on available hepatitis B and hepatitis C testing programs into any liver cancer presentations carried out by the entity; and target communities and populations with a higher risk for contracting liver cancer and other liver diseases. In awarding grants under paragraph (1), the Secretary shall give preference to entities that— are, or work with, a Federally-qualified health center; or are community-based organizations. An entity that receives a grant under paragraph

Connectionstraces to 1

Traces to 1 document

U.S. Code

Health centers
§ 254b

Citation graph

cites case law

Sec. 4

Liver cancer and disease prevention, awareness, and patient tracking grants

U.S.C.§ 254b

Cites 1Cited by 0 across 0 sources